Robotic surgery is now widely applied and relevant to almost every surgical subspecialty.
This webinar will summarize the most important medical, technical, and economic issues facing the field. We will also discuss new platforms, navigation, and artificial intelligence. The goals are to engage in a conversation summarizing current art and anticipating future breakthroughs in surgical robotics.
About the speaker
Dr. Fong is best known clinically for his work in the field of liver and pancreatic surgery. His work helped establish hepatic resection of colorectal metastases as a safe, effective, and potentially curative option even at stage IV. He also helped in ushering in robotic techniques for HPB surgery. He is editor of The SAGES Atlas of Robotic Surgery. For his clinical work, he was awarded the Layton F. Rikkers Master Clinician Award from the SSAT. He has assisted in the design and deployment of many novel surgical tools and gene manipulation tools. His work in medical engineering has led to his election to the American Institute of Medical and Biological Engineering.
Dr. Fong’s laboratory is focused on the field of gene therapy. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health. He is currently Editor-in-Chief of Molecular Therapy-Oncolytics (Cell Press). He has co-authored over 950 peer-reviewed articles and 20 textbooks (h-index>137). His papers have been cited >79,000 times.
